«Antibody for severe hemophilia a may reduce injections needed to prevent bleeding: First - in - human study of ACE910 suggests excessive bleeding prevention is possible with
a weekly subcutaneous injection compared to standard two or three intravenous injections every week, and should be effective in treating patients with inhibitors.»
Doramectin — Doramectin, another avermectin, has been used in a study involving 23 dogs that received
weekly subcutaneous injections of 600 µg / kg.10, 31 None of the animals showed adverse effects with doramectin; however, this drug should not be used in ivermectin - sensitive breeds of dogs.
Not exact matches
The control group remained untreated and the treated groups received daily
subcutaneous injection of MIA - 602 (5µg / day) and / or
weekly intravenous (jugular)
injections of doxorubicin (2.5 nmol / kg / wk).